Canary Speech to Showcase AI-Driven Vocal Biomarker Technology at HIMSS Conference
Canary Speech has cultivated a strategic collaboration with Microsoft, leveraging Microsoft Cloud for Healthcare, to scale its operations across the U.S., Japan, U.K., and South America. The company’s technology is also available on the Microsoft Azure Marketplace.
“Microsoft’s commitment to working with partners is helping drive digital transformation in healthcare,” said Henry O’Connell, CEO and co-founder of Canary Speech. “The opportunities provided by Microsoft are helping us transform our business to deliver impactful, human-centered solutions. AI-enabled vocal biomarkers, powered by Microsoft’s ambient listening technology, are revolutionizing healthcare by providing objective, real-time insights that enhance clinical decision-making.”
“At Canary Speech, we believe that voice is the next vital sign—empowering clinicians with cutting-edge tools to drive digital transformation and improve patient outcomes.”
Canary Speech credits its relationship with Microsoft with elevating its perspective on future positioning. Through advanced analysis of speech biomarkers via AI and machine learning techniques, Canary Speech’s proprietary technology offers a new approach to gathering and measuring critical data, supplementing current behavioral health assessments.
As part of the ongoing strategic collaboration, Canary Speech is also among the early Microsoft partners exploring and validating the integration of its speech technology into the Microsoft Dragon Copilot ambient listening platform. This integration has the potential to offer increased value to provider organizations.
“At Microsoft, we are committed to driving transformation by enabling a rich ecosystem of partners to extend the capabilities of our ambient listening technology through innovative relationships. Our collaboration with Canary Speech exemplifies this commitment,” said Kenneth Harper, General Manager, Dragon Product, Microsoft. “We look forward to the positive impact our work together will have on healthcare organizations, their providers and the patients they serve.”
For more information about Canary Speech, visit the Microsoft Booth #2221 located on Level 2 of The Venetian Convention & Expo Center, 201 Sands Avenue, Las Vegas, or email [email protected].
About Canary Speech
Canary Speech is a leading AI-powered voice biomarker health tech company leveraging real-time patented vocal analysis to screen for mental health and neurological disorders. The company’s technology rapidly analyzes speech data to identify irregularities in behavioral and cognitive changes, potentially detecting conditions like anxiety, depression, and dementia before clinical standards or noticeable symptoms.
Canary Speech is a Utah-based company dedicated to advancing speech and language applications for health systems, payers, and pharmaceutical markets.
Contact
Caitlyn Brooksby VP Marketing & Strategic Partnerships Canary Speech [email protected]
